Johnson & Johnson stock last trades at USD 272.24 on September 28, 2026
Published on 09/28/2026 at 20:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Trading session
Johnson & Johnson stock last traded at USD 272.24 on the NYSE on September 28, 2026, at 18:02:10 UTC. The shares were up USD 1.01, or 0.37 percent, from the previous close.
Company developments
In a September 21, 2026 release, Johnson & Johnson said its Phase 3 study of CAPLYTA in adults with bipolar I disorder and manic episodes met its primary endpoint. The company reported a statistically significant reduction in manic symptoms versus placebo at Week 3, with significant improvement observed as early as Day 3. CAPLYTA is not approved for manic episodes associated with bipolar I disorder.
In a September 14, 2026 release, Johnson & Johnson reported final overall-survival results from the Phase 3 PAPILLON study of first-line RYBREVANT plus chemotherapy in advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Median overall survival was 34.3 months with the combination versus 27.9 months with chemotherapy alone. The findings were presented at the 2026 World Conference on Lung Cancer.
